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Abstract
Objective—The aim of our study was to compare the age-standardized incidence of esophageal
cancer (EC) in Puerto Ricans (PRs) with that for non-Hispanic White (NHW), non-Hispanic Black
(NHB), and Hispanic (USH) groups in the United States (US) as reported by the Surveillance,
Epidemiology, and End Results program for the 1992–2005 period.
Methods—We computed age-standardized and age-specific incidence (per 100,000 individuals)
of EC during 1992 to 2005 using the World Standard Population as reference. The percent
changes for age-standardized incidences, from 1992–1996 to 2001–2005, were calculated. The
relative risks (RR) and the standardized rate ratios (SRR) were estimated, along with 95%
confidence intervals (CI).
Results—Age-standardized rates (ASR) of adenocarcinomas (AC) showed increases for most
racial/ethnic groups from 1992–1996 to 2001–2005. All racial/ethnic groups showed ASR
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reductions for squamous cell carcinomas (SCC). For both sexes, PRs had lower AC incidences
than NHW and USH but higher than NHB. For those younger than 80 years of age, PR men
showed higher SCC incidences than NHW but lower than NHB (P < 0.05). The incidence of SCC
was about two times higher in PR men than USH men (SRR: 2.16; 95% CI = 1.65–2.88). Among
women, the RR for SCC increased with age when comparing PRs to groups in the US.
Conclusion—Incidence disparities were observed between PRs and other racial/ethnic groups in
the US. These differences and trends may reflect lifestyles of each racial/ethnic group. Further
studies are warranted to explain these disparities.
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1. Introduction
Esophageal cancer (EC) has been ranked as the 8th most common cancer and the 6th most
common cause of cancer death in the world.[1] The American Cancer Society estimated a
total of 16,980 new cases and 14,710 deaths from EC for the year 2011 in the United States
of America (US).[2] Nonetheless, countries like Iran, India, South Africa, and north China
present rates that are 10 to 100 times higher than the US.[2] Also, relative to the World
Standard Population, the Puerto Rican (PR) population has higher age-standardized
incidence per 100,000 individuals than the US, in both men (7.3 vs. 5.8) and women (1.9 vs.
1.2).[1]
In the US, different incidence and mortality trends have been seen between racial and ethnic
groups. The US Hispanic (USH) population, for example, has lower EC incidence than the
non-Hispanic white (NHW) and non-Hispanic black (NHB) populations; the latter group
having the highest rates.[3,4] In addition, men clearly present a higher risk of developing EC
than women.[3,5,6] Distinct geographic, racial, and sex differences play an important role in
EC trends.
During the past several decades, the sudden increase in EC incidence has become a major
concern in healthcare. This increase has been explained by the rise of esophageal
adenocarcinoma (AC) [7], which is one of the main histology types of EC along with
squamous cell carcinoma (SCC). During the early 1980s, AC accounted for <15% of all EC
whereas now it represents >60% [5], displacing SCC and becoming the most common
histological type of EC in the US and western Europe.[7,8] The incidence of SCC has
decreased by 3.6% per year between 1998 and 2003 while that of AC increased 2.1%.[6] In
the US, most of the increase in AC has occurred in NHW of both sexes.[9,10] Nonetheless,
SCC remains 6 times more likely to occur in black men than in white men.[11]
The comparison of PR cancer statistics with those of racial/ethnic groups in the US is of
interest because of the sociocultural relationship between Puerto Rico and the US.[12] Such
a comparison is not only necessary to understand differences and similarities in EC
occurrence but could also provide relevant information on the influence of different factors
on disease occurrence. We know of no comparison between PRs and US groups for a recent
period or for the different histological types of EC. The aim of our study was to compare the
age-standardized incidence of EC in PRs with that for USH, NHW, and NHB groups in the
US as reported by the Surveillance, Epidemiology, and End Results (SEER) program for the
period 1992–2005.
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As described in other studies [13,14], data sources for this analysis included the SEER
program and the Puerto Rico Cancer Center Registry (PRCCR). The PRCCR, part of the
National Program of Cancer Registries, is administered by the Centers for Disease Control
and Prevention (CDC) and uses the coding standards of the SEER program and of the North
American Association of Central Cancer Registries, which makes the registry’s data fully
comparable to the SEER data. The criteria specified in the third revision of the International
Classification of Diseases for Oncology (ICD-O-3) were used to select all cases of EC from
2001 and later (site codes C150–C155 and C158-159) for this analysis.[15] Cases from 1992
to 2000 were originally reported using ICD-O-2 and later converted to ICD-O-3 by the
SEER program.[16] Esophageal cancer incidences data from 1992 to 2005 for PRs were
obtained from the PRCCR. Esophageal cancer incidences cases for 1992 to 2005 for each
racial/ethnic group (NHW, NHB, and USH) in the US assessed in this study were obtained
with the SEER*Stat 6.3.5 software (National Cancer Institute Surveillance Program,
Bethesda, MD) and were based on SEER 13 registries database which includes the
following cities and states: Atlanta (Georgia), Connecticut, Detroit (Michigan), Hawaii,
Iowa, New Mexico, San Francisco-Oakland (California), Seattle-Puget Sound (Washington),
Utah, Los Angeles (California), San Jose-Monterey (California), Rural Georgia, and the
Alaska Tumor Registry. Hispanic ethnicity was identified by the SEER program using a
combination of medical record review and matching surnames against a list of Hispanic
surnames.[17] This study does not account for racial differences within the USH population.
2.2 Statistical Analysis
For each racial/ethnic group, we applied the direct method to compute EC age-standardized
incidence (per 100,000 individuals) during 1992 to 2005 using the World Standard
Population as reference.[18] To assess the trend of EC risk by sex from 1992–1996 to 2001–
2005 period, we calculated the annual age-standardized rates [ASR (World)] for each period
(1992–1996,1997–2000, and 2001–2005), as follows:
where j represents a given age group, i represents a given ethnic group, k represents a given
period, w is the proportion of people in the world population to be evaluated, d is the
number of new cases or deaths, and n is the total population. The change in the ASR from
the earliest and the latest study period (1992–1996 and 2001–2005) was calculated as a
percentage as follows:
The significance of the percentage of change was determined by 95% confidence intervals
(CIs) using the formulas from the US Census Bureau.[19] If zero was not included in this
interval, significance was set at a P-value less than 5%.
To assess racial/ethnic group differences, we grouped the ASR(World) values during the
study period (2001–2005) as follows:
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Then, the ratio of two standardized rates [ASR (World)groupi/ASR (World)groupj] between
any two groups (i and j) was estimated with 95% CIs [20] to assess differences in EC
incidence between the PR group and USH, NHB, and NHW groups. This ratio is referred to
as the standardized rate ratio (SRR).
In addition, age-specific incidence (per 100,000 individuals) for different age groups was
computed by sex for 2001–2005. On the basis of these rates, the relative risks (RR) were
estimated with 95% CIs to determine relative differences among the study groups by sex and
10-year age group (50–59, 60–69, 70–79, and ≥ 80) using the Poisson regression model.[21]
The interaction between age groups and racial/ethnic groups was also assessed using the
likelihood ratio test. The reference groups in the age-specific RR estimation were NHW,
NHB, and USH, each stratified by sex. The regression was performed using Stata/SE
version 11.0 statistical software (Stata Corp., LP., College Station, TX).
3. Results
3.1 Trends of ASR(World)
All EC—Among men, NHW and USH showed an ASR(World) increase, from 1992–1996
to 2001–2005, but it was only significant for NHW (% change = 18.2; P < 0.05). On the
other hand, both NHB men and PR men had significant reductions over time (P < 0.05;
Table 1). Among women, the only observed increase was not statistically significant and
occurred in NHW (% change = 1.1; P > 0.05). In contrast, PR, USH, and NHB women all
had ASR(World) that decreased from 1992–1996 to 2001–2005. Only PR and NHB women
had a significant decline (% change in PR = −44.8 and % change in NHB= −20.3; P < 0.05
for both).
AC and SCC—Age-standardized rates of AC showed increases for most racial/ethnic
groups from 1992–1996 to 2001–2005 (Table 1). Despite the increase of AC in most of the
groups, significant changes were only seen in NHW (% change in men = 44.6 and % change
in women = 45.8; P < 0.05 for both sexes). Moreover, an AC reduction was observed among
NHB men (% change = −12.5); however, this reduction was not significant (P > 0.05).
Conversely, all racial/ethnic groups showed ASR reductions in squamous cell carcinoma
from 1992–1996 to 2001–2005 (Table 1). The greatest incidence reductions for SCC were
observed for PRs (% change in men = −44.2 and % change in women = −48.7; P < 0.05 for
both sexes).
3.2 SRR and RR (2001–2005 period)
All EC—An age and racial/ethnic group interaction was observed when comparing EC
incidence of PRs to those of NHB and NHW; a lower incidence for PRs was observed
among persons between 50 and 79 years of age (Table 2). On the contrary, the oldest age
group (≥80 years) showed consistently higher incidence for PRs than for NHB and NHW; it
was only significant for the comparison between PR and NHB men (Table 2). For both
sexes, PRs had higher incidences of all EC than USH did (SRR men: 1.40, 95% CI = 1.16–
1.69; and SRR women: 1.88, 95% CI = 1.37–2.63) with no evidence of age and racial/ethnic
group interaction (P > 0.05).
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AC and SCC—None of the comparisons of AC incidence between PRs and the other
racial/ethnic groups showed evidence of an interaction between age and racial/ethnic group
(P > 0.05) (Table 3). For both sexes, PR had lower incidences of AC than NHW and USH
but higher AC incidences than NHB (Table 3). Puerto Rican men had about two times the
incidence of AC that NHB men did (SSR: 2.32, 95% CI = 1.51, 3.71).
Conversely to AC, for SCC, we found an interaction between age and racial/ethnic group
when comparing incidences in PR women with those of NHW, NHB, and USH women.
Among women, the RR for SCC increased with age (Table 4). Among men, PRs showed
higher SCC incidences than NHW but lower than NHB for people younger than 80 years of
age (P < 0.05; Table 4). The incidence of SCC was about two times higher in PR men than
USH men (SRR: 2.16; 95% CI = 1.65–2.88).
4. Discussion
The results of this study indicate that EC incidences in PRs, depending on the EC
histological type, differ from those in other racial/ethnic groups in the US. When
histological types were evaluated separately, NHW showed the highest incidence of AC,
whereas NHB showed the highest incidence of SCC for most of the periods studied. We
found the incidence of AC was lower in PRs than in NHW and USH but higher than in
NHB, whereas the incidence trends of SCC were generally opposite those of AC. As
previously seen in other studies, the incidence of EC, both in PRs and the other racial/ethnic
groups, was higher among men than women.[3,5,6,12,22] Partly, incidence differences
between the sexes could be explained by differences in alcohol consumption and tobacco
use [23,24], which have been strongly associated with SCC.[25,26]
Despite the elevated incidence of all EC in PRs, the island showed one of the largest
declines in SCC incidence between 1992–1996 and 2001–2005 (Table 1). Behavioral Risk
Factor Surveillance System (BRFSS) data [27] might explain why the SCC incidence has
decreased in Puerto Rico and the US: from 1997 to 2010, the use of cigarettes decreased in
both regions (14.4% to 11.9%in PRs and 23.2% to 17.3% in the US). Puerto Ricans had a
lower prevalence of current smokers than the US during this period, but at the same time,
the NHB population in the US had the highest prevalence [27], potentially explaining why
the PRs showed a lower incidence of SCC than NHB in the US (P < 0.05) for both sexes.
Despite a lower prevalence of current smokers, the PR population doubled and tripled the
risk (P < 0.05) for SCC as compared to NHW and USH population, which could be
explained by the duration of tobacco consumption rather than the number of cigarettes
smoked by current smokers.[23,28] In addition, the prevalence of heavy drinkers also
decreased slightly in Puerto Rico (3.8% to 3.0%) and the US (5.1% to 5.0%) from 2001 to
2010; NHW consistently showed the highest prevalence of drinking during this period,
whereas the lowest prevalence has been frequently observed in NHB.[27] Furthermore, the
risk of SCC does not seem to depend on the duration of alcohol consumption but on the
mean daily intake [23,28], which could influence our results. The period effects for both
factors (alcohol consumption and smoking) must also be considered.
One factor that has been continuously related to a reduction in the risk of SCC is a diet high
in fiber and vitamins.[29,30] One of the major sources for fiber and vitamins is fruits and
vegetables. From 1996–2009, the prevalence of persons in Puerto Rico consuming more
than 5 servings of fruits and/or vegetables per day was 7.2% in 2000 and 17.7% in 2009.[27]
In the US, the overall prevalence of consuming fruits two or more times per day decrease
significantly from 34.4% to 32.4% whereas no significant change was observed for
consuming vegetables three or more times per day (26.7% in 2000 and 26.3% in 2009).[31]
Although our study design cannot make any assessment of biological relevance of fruits and
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vegetables consumption on the development of EC these estimates could support the
hypothesis that differences in EC between PR and other US racial/ethnic groups exist.
In opposition to the trends seen in SCC, PR and the other racial/ethnic groups in the US,
except NHB men and PR women, showed an increased incidence of AC in the time periods
from 1992–1996 to 2001–2005. The rise of AC could be due to an elevated exposure to risk
factors such as obesity, gastroesophageal reflux disease (GERD), and Barrett’s esophagus
(BE), which have been consistently related to this histological type. For example, it has been
suggested that obesity trends are temporally consistent with the epidemiology of AC.[32]
Cossrow and Falkner [33] stated that the biggest rise in obesity rates was observed among
NHB women, followed by USH and NHW women. This could explain why the largest
change in AC incidence was observed for NHB women during the 1992–2005 period (%
change = 85.7), although not significant.
Obesity is associated with about twice the risk of AC (OR: 2.2, 95%CI: 1.1–4.3) as
compared to a normal body mass index (BMI).[34] Data from the BRFSS showed that
62.4% of NHW, 72.3% of NHB, and 65.4% of USH were overweight or obese in 2007.[27]
Likewise, Pérez et al [35] found that 77.5% of the PR population (n=859) were overweight
or obese and 49.0% showed excess of abdominal fat. Although the rate of obesity seems to
be higher in the PR population than in the US population, an increased risk of esophageal
AC was only observed when comparing PRs to NHB. However, excessive visceral adipose
tissue (VAT) instead of BMI has been considered the main factor associated with
developing AC among obese people.[36] Researches have found that larger VAT levels are
more likely related to European genetic admixtures than to African genetic admixtures (P <
0.013 and P < 0.001, respectively) [37], which could be responsible for the higher risks of
AC in the PR population than NHB but lower than NHW and USH. Furthermore, men have
greater propensity than women to accumulate excess fat within the abdominal cavity despite
the fact that women as a group tend to be more obese than men, which could be another
explanation for incidence differences between the sexes.[38]
The effect of obesity, as well as GERD, may be a critical factor in the increased incidence of
AC observed in this study. The prevalence of GERD in the US has been estimated to be
25%–35%.[39] According to the American Society for Gastrointestinal Endoscopy [40], 10
to 15% of patients with GERD develop BE and consequently are predisposed to AC. Data
on GERD’s prevalence in PRs have not been published; a questionnaire is in the process of
being validated for this purpose.[41] Nevertheless, Altman et al. [42] have indicated that an
increase in the proportion of US primary care visits for GERD occurred between the periods
of 1990–1993 and 1998–2001 making this a reasonable explanation for an increase in AC
incidence. However, BE could also be playing an important role in AC incidence rates and
trends differences. Barrett’s esophagus, which is a strong risk factor for AC and is a
complication of chronic GERD, has shown significant differences by racial/ethnic group and
sex in the US.[43,44]
4.1 Strengths and limitations
This study provided updated population-based data on EC, by histological type and overall,
in PRs compared to racial/ethnic groups in the US. According to a CDC audit in the year
2003, 95.3% of all cancer cases diagnosed or treated in hospital facilities in Puerto Rico
were appropriately reported to the PRCCR, which is a rate comparable to the US median
(95%). However, some limitations of this study should be acknowledged. First, we were
unable to collect data on individual risk factors because neither the PRCCR nor the SEER 13
program collects this information. However, our results suggest differences in rates and
trends which may reflect different lifestyles across races and ethnicities. Second, our results
may have been influenced by poor accuracy in the classification of Hispanic cancer cases in
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the SEER 13 program. Nevertheless, results from a previous study showed that bias, when
classifying cancer cases as USH, can be reduced by combining surname and medical record
information.[45] Since this method has been used by the SEER 13 program when classifying
persons as USH we do not expect major changes in our conclusions.
5. Conclusions
Despite the reduction of SCC incidences in PRs and all the racial/ethnic groups in the US (P
< 0.05), data in this study show that SCC was still more common than AC among PR and
NHB for each period (1992–1996, 1997–2000, and 2001–2005; Table 1). This result
suggests it is necessary to continue addressing the substantial burden of SCC in these
populations. Although there has been a great reduction in tobacco use, it is crucial to
continue promoting and strengthening a healthy lifestyle including healthy dietary habits,
reduced alcohol consumption, and reduced tobacco use. According to Doll and Peto [46],
populations can achieve an 86% reduction in the risk of aerodigestive tract cancers by
avoiding tobacco and alcohol use and increasing fruit and vegetable consumption; a 20%
reduction in risk can be attributed to dietary change alone. Improving dietary habits can not
only serve as a protective factor for SCC, as suggested by others researchers [47–50], but
could also indirectly help reduce AC incidence because majorrisk factors for this histology
are related to diet.[51]
In conclusion, incidence disparities were observed between PRs and other racial/ethnic
groups in the US. As is seen for other types of cancer, these differences and trends may
reflect lifestyles of each racial/ethnic group. Further studies are warranted to explain the
disparities in EC incidence by racial/ethnic group.
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